Clinical Trial Update: Statin for Neuroprotection in Spontaneous Intracerebral Hemorrhage [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for a statin being investigated for neuroprotection in spontaneous intracerebral hemorrhage (Phase 2/Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage

Drugs mentioned

• Statins

Snippet

Sponsor: Capital Medical University | Conditions: Intracerebral Hemorrhage, Statins | Phase 2, Phase 3 | Status: UNKNOWN